Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT06411795Phase 2Recruiting
- Sponsor
- Masonic Cancer Center
- Start
- Nov 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal bupivacaine in postoperative pain, sponsored by Masonic Cancer Center. Started Nov 2023; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06411795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411795.